肝脏 ›› 2021, Vol. 26 ›› Issue (3): 284-286.

• 肝癌 • 上一篇    下一篇

氟西汀影响HepG2细胞增殖和凋亡的机制

刘晓慧, 马丽霞, 张晶   

  1. 100069 首都医科大学附属北京佑安医院丙肝与中毒性肝病科
  • 收稿日期:2020-08-31 发布日期:2021-04-21
  • 通讯作者: 张晶,Email:drzhangjing@163.com

The effect of fluoxetine on proliferation and apoptosis of HepG2 cells and its mechanism

LIU Xiao-hui, MA Li-xia, ZHANG Jing   

  1. Department of Hepatitis C and Drug Induced Liver Injury, Beijing Youan Hospital, Capital Medical University,Beijing 100069,China
  • Received:2020-08-31 Published:2021-04-21
  • Contact: ZHANG Jing, Email: drzhangjing@163. com

摘要: 目的 探讨氟西汀影响HepG2细胞增殖和凋亡的机制。 方法 以不同浓度氟西汀分别处理HepG2细胞24 h,应用流式细胞术检测不同浓度氟西汀对HepG2细胞周期影响;给予HepG2细胞12.5 μmol氟西汀分别处理0、6、12和24 h,采用荧光定量PCR法检测HepG2细胞不同时间点Bcl-2、Bax mRNA表达,采用蛋白质印迹方法检测HepG2细胞不同时间点Bcl-2、Bax、caspase-3的蛋白表达。 结果 流式细胞术检测细胞周期结果显示,对照组、5 μmol、10 μmol、12.5 μmol氟西汀处理HepG2细胞24 h,G2/M期细胞数分别为(9.63±0.33)%、(10.12±0.86)%、(19.68±4.31)%、(22.74±2.46)%,10 μmol、12.5 μmol组与对照组相比,差异均有统计学意义(均P<0.05);12.5μmol氟西汀处理HepG2细胞0、6、12和24 h后,随着氟西汀孵育时间延长,HepG2细胞Bcl-2的mRNA表达逐渐降低,各组与对照组相比,差异均有统计学意义(均P<0.05);而HepG2细胞Bax的mRNA表达各组与对照组相比,差异均无统计学意义(均P>0.05);HepG2细胞Bcl-2蛋白表达在12h开始下降,Bax蛋白表达无明显变化,Bax/Bcl-2及caspase-3蛋白表达在12h开始增多。 结论 氟西汀通过干扰人肝癌细胞系HepG2细胞周期、降低抗凋亡蛋白Bcl-2的表达和促进caspase-3活化,抑制HepG2细胞增殖并诱导其发生凋亡。

关键词: HepG2细胞, 氟西汀, 增殖, 凋亡, 机制

Abstract: Objective To investigate the effect of fluoxetine on proliferation and apoptosis of HepG2 cells and its mechanism. Methods We treated HepG2 cells with different concentrations of fluoxetine respectively for 24 hours. Flow cytometry was used to detect cell cycle of HepG2 cells treated with different concentrations of fluoxetine. In HepG2 cells treated with 12.5 μM fluoxetine for 0, 6, 12 and 24 hours, real-time polymerase chain reaction were used to detect the mRNA expressions of Bcl-2 and Bax, and Western bolt was used to detect the protein expressions of Bcl-2, Bax and caspase-3. Results It was showed that the cell percentages in G2/M phase were 9.63% ± 0.33%, 10.12% ± 0.86%, 19.68% ± 4.31% and 22.74% ± 2.46% after HepG2 cells treated with control, 5 μM, 10 μM and 12.5 μM of fluoxetine for 24 hours, respectively. And the cell percentages in G2/M phase in 10 μM and 12.5 μM groups were statistically different from that in control group (both P<0.05). The mRNA levels of Bcl-2 in HepG2 cells were gradually reduced as the time of incubating with 12.5μM fluoxetine increased (0, 6, 12 and 24 hours). The differences were statistically significant between the 0-hour group and other groups, respectively (all P<0.05). While there was no statistical difference in the Bax mRNA levels between control and other groups, respectively (all P>0.05). The protein expression level of Bcl-2 began to decrease after 12-hour incubation while the protein expression level of Bax was not significantly changed. The protein expression levels of Bax/Bcl-2 and caspase-3 began to increase after 12-hour incubation. Conclusion Through influencing HepG2 cell cycle, reducing the expression of anti-apoptotic protein Bcl-2 and activating caspase-3, fluoxetine can inhibit proliferation and induce apoptosis of HepG2 cells.

Key words: HepG2 cell, Fluoxetine, Proliferation, Apoptosis, Mechanism